Vital Farms (NASDAQ:VITL - Get Free Report) is expected to be issuing its Q1 2025 quarterly earnings data before the market opens on Thursday, May 8th. Analysts expect Vital Farms to post earnings of $0.27 per share and revenue of $164.43 million for the quarter. Vital Farms has set its FY 2025 guidance at EPS.
Vital Farms (NASDAQ:VITL - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.15 by $0.08. The firm had revenue of $165.99 million for the quarter, compared to the consensus estimate of $160.32 million. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%. On average, analysts expect Vital Farms to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Vital Farms Stock Up 0.3 %
NASDAQ:VITL traded up $0.11 during trading hours on Tuesday, reaching $35.65. The company's stock had a trading volume of 160,285 shares, compared to its average volume of 1,038,275. The stock has a 50 day moving average price of $32.26 and a two-hundred day moving average price of $35.13. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24. The company has a market capitalization of $1.59 billion, a P/E ratio of 31.77 and a beta of 0.94. Vital Farms has a 12 month low of $27.91 and a 12 month high of $48.41.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the company. William Blair reaffirmed an "outperform" rating on shares of Vital Farms in a research report on Friday, February 28th. BMO Capital Markets initiated coverage on shares of Vital Farms in a report on Monday. They issued an "outperform" rating and a $44.00 price target on the stock. Morgan Stanley cut their price objective on shares of Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Stifel Nicolaus raised shares of Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 target price for the company in a research report on Friday, February 28th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and issued a $52.00 price target on shares of Vital Farms in a report on Monday. Nine analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $44.63.
View Our Latest Report on VITL
Insider Activity
In related news, CEO Russell Diez-Canseco sold 45,124 shares of the stock in a transaction on Monday, April 14th. The shares were sold at an average price of $33.69, for a total transaction of $1,520,227.56. Following the sale, the chief executive officer now directly owns 703,736 shares of the company's stock, valued at approximately $23,708,865.84. This represents a 6.03 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Matthew Ohayer sold 4,000 shares of Vital Farms stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $31.39, for a total value of $125,560.00. Following the completion of the transaction, the insider now owns 6,966,890 shares of the company's stock, valued at approximately $218,690,677.10. This represents a 0.06 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 93,124 shares of company stock valued at $3,019,308 over the last ninety days. 27.60% of the stock is currently owned by insiders.
Vital Farms Company Profile
(
Get Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
See Also

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.